Caricamento...
Precision medicine in lupus nephritis: can biomarkers get us there?
Patients with systemic lupus erythematosus (SLE) frequently develop lupus nephritis (LN), a condition that can lead to end stage kidney disease (ESKD). Multiple serum and urine biomarkers for LN have been proposed in recent years, yet none have become incorporated into clinical use. The majority of...
Salvato in:
| Pubblicato in: | Transl Res |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6415919/ https://ncbi.nlm.nih.gov/pubmed/30179587 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.trsl.2018.08.002 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|